Business
Press Release Jul 12 2023
Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated July 12, 2023, titled "Dr. Reddy s proposed rituximab biosimilar application accepted for review by USFDA, EMA and MHRA".
About this update from Dr. Reddy's Laboratories Ltd.
[{"type":"text","content":" Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated July 12, 2023, titled \"Dr. Reddy s proposed rituximab biosimilar application accepted for review by USFDA, EMA and MHRA\". View Attachment","length":364,"tagName":"div"}]